Page 45 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) – Investment analysts at Zacks Research upped their FY2023 earnings estimates for Charles River Laboratories International in a report released on Wednesday, May 24th. Zacks Research analyst U. Biswas now forecasts that the medical research company will post earnings of $10.22 per share for the year, […]

/PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in...

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 29.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 45,474 shares of the medical research company’s stock after acquiring an additional 10,450 […]

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts... | May 28, 2023

Morningstar Investment Services LLC lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 3.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,655 shares of the medical research company’s stock after purchasing an additional 220 shares […]